The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharma-Grade Nitric Oxide Market Research Report 2025
Synopsis
Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).
The global Pharma-Grade Nitric Oxide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
This report aims to provide a comprehensive presentation of the global market for Pharma-Grade Nitric Oxide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma-Grade Nitric Oxide.
Report Scope
The Pharma-Grade Nitric Oxide market size, estimations, and forecasts are provided in terms of sales volume (K CBM) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharma-Grade Nitric Oxide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma-Grade Nitric Oxide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Inomax
Praxair
Air Liquide
Novoteris
Segment by Type
99.92% Purity
99.99% Purity
Segment by Application
Hospitals
Healthcare Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharma-Grade Nitric Oxide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharma-Grade Nitric Oxide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).
The global Pharma-Grade Nitric Oxide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
This report aims to provide a comprehensive presentation of the global market for Pharma-Grade Nitric Oxide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma-Grade Nitric Oxide.
Report Scope
The Pharma-Grade Nitric Oxide market size, estimations, and forecasts are provided in terms of sales volume (K CBM) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharma-Grade Nitric Oxide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma-Grade Nitric Oxide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Inomax
Praxair
Air Liquide
Novoteris
Segment by Type
99.92% Purity
99.99% Purity
Segment by Application
Hospitals
Healthcare Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharma-Grade Nitric Oxide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharma-Grade Nitric Oxide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pharma-Grade Nitric Oxide Market Overview
1.1 Product Overview and Scope of Pharma-Grade Nitric Oxide
1.2 Pharma-Grade Nitric Oxide Segment by Type
1.2.1 Global Pharma-Grade Nitric Oxide Market Value Comparison by Type (2024-2030)
1.2.2 99.92% Purity
1.2.3 99.99% Purity
1.3 Pharma-Grade Nitric Oxide Segment by Application
1.3.1 Global Pharma-Grade Nitric Oxide Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Healthcare Centers
1.3.4 Others
1.4 Global Pharma-Grade Nitric Oxide Market Size Estimates and Forecasts
1.4.1 Global Pharma-Grade Nitric Oxide Revenue 2019-2030
1.4.2 Global Pharma-Grade Nitric Oxide Sales 2019-2030
1.4.3 Global Pharma-Grade Nitric Oxide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pharma-Grade Nitric Oxide Market Competition by Manufacturers
2.1 Global Pharma-Grade Nitric Oxide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pharma-Grade Nitric Oxide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pharma-Grade Nitric Oxide Average Price by Manufacturers (2019-2024)
2.4 Global Pharma-Grade Nitric Oxide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharma-Grade Nitric Oxide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharma-Grade Nitric Oxide, Product Type & Application
2.7 Pharma-Grade Nitric Oxide Market Competitive Situation and Trends
2.7.1 Pharma-Grade Nitric Oxide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharma-Grade Nitric Oxide Players Market Share by Revenue
2.7.3 Global Pharma-Grade Nitric Oxide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharma-Grade Nitric Oxide Retrospective Market Scenario by Region
3.1 Global Pharma-Grade Nitric Oxide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pharma-Grade Nitric Oxide Global Pharma-Grade Nitric Oxide Sales by Region: 2019-2030
3.2.1 Global Pharma-Grade Nitric Oxide Sales by Region: 2019-2024
3.2.2 Global Pharma-Grade Nitric Oxide Sales by Region: 2025-2030
3.3 Global Pharma-Grade Nitric Oxide Global Pharma-Grade Nitric Oxide Revenue by Region: 2019-2030
3.3.1 Global Pharma-Grade Nitric Oxide Revenue by Region: 2019-2024
3.3.2 Global Pharma-Grade Nitric Oxide Revenue by Region: 2025-2030
3.4 North America Pharma-Grade Nitric Oxide Market Facts & Figures by Country
3.4.1 North America Pharma-Grade Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pharma-Grade Nitric Oxide Sales by Country (2019-2030)
3.4.3 North America Pharma-Grade Nitric Oxide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pharma-Grade Nitric Oxide Market Facts & Figures by Country
3.5.1 Europe Pharma-Grade Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pharma-Grade Nitric Oxide Sales by Country (2019-2030)
3.5.3 Europe Pharma-Grade Nitric Oxide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharma-Grade Nitric Oxide Market Facts & Figures by Country
3.6.1 Asia Pacific Pharma-Grade Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pharma-Grade Nitric Oxide Sales by Country (2019-2030)
3.6.3 Asia Pacific Pharma-Grade Nitric Oxide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pharma-Grade Nitric Oxide Market Facts & Figures by Country
3.7.1 Latin America Pharma-Grade Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pharma-Grade Nitric Oxide Sales by Country (2019-2030)
3.7.3 Latin America Pharma-Grade Nitric Oxide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharma-Grade Nitric Oxide Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharma-Grade Nitric Oxide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pharma-Grade Nitric Oxide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pharma-Grade Nitric Oxide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharma-Grade Nitric Oxide Sales by Type (2019-2030)
4.1.1 Global Pharma-Grade Nitric Oxide Sales by Type (2019-2024)
4.1.2 Global Pharma-Grade Nitric Oxide Sales by Type (2025-2030)
4.1.3 Global Pharma-Grade Nitric Oxide Sales Market Share by Type (2019-2030)
4.2 Global Pharma-Grade Nitric Oxide Revenue by Type (2019-2030)
4.2.1 Global Pharma-Grade Nitric Oxide Revenue by Type (2019-2024)
4.2.2 Global Pharma-Grade Nitric Oxide Revenue by Type (2025-2030)
4.2.3 Global Pharma-Grade Nitric Oxide Revenue Market Share by Type (2019-2030)
4.3 Global Pharma-Grade Nitric Oxide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pharma-Grade Nitric Oxide Sales by Application (2019-2030)
5.1.1 Global Pharma-Grade Nitric Oxide Sales by Application (2019-2024)
5.1.2 Global Pharma-Grade Nitric Oxide Sales by Application (2025-2030)
5.1.3 Global Pharma-Grade Nitric Oxide Sales Market Share by Application (2019-2030)
5.2 Global Pharma-Grade Nitric Oxide Revenue by Application (2019-2030)
5.2.1 Global Pharma-Grade Nitric Oxide Revenue by Application (2019-2024)
5.2.2 Global Pharma-Grade Nitric Oxide Revenue by Application (2025-2030)
5.2.3 Global Pharma-Grade Nitric Oxide Revenue Market Share by Application (2019-2030)
5.3 Global Pharma-Grade Nitric Oxide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Inomax
6.1.1 Inomax Corporation Information
6.1.2 Inomax Description and Business Overview
6.1.3 Inomax Pharma-Grade Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Inomax Pharma-Grade Nitric Oxide Product Portfolio
6.1.5 Inomax Recent Developments/Updates
6.2 Praxair
6.2.1 Praxair Corporation Information
6.2.2 Praxair Description and Business Overview
6.2.3 Praxair Pharma-Grade Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Praxair Pharma-Grade Nitric Oxide Product Portfolio
6.2.5 Praxair Recent Developments/Updates
6.3 Air Liquide
6.3.1 Air Liquide Corporation Information
6.3.2 Air Liquide Description and Business Overview
6.3.3 Air Liquide Pharma-Grade Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Air Liquide Pharma-Grade Nitric Oxide Product Portfolio
6.3.5 Air Liquide Recent Developments/Updates
6.4 Novoteris
6.4.1 Novoteris Corporation Information
6.4.2 Novoteris Description and Business Overview
6.4.3 Novoteris Pharma-Grade Nitric Oxide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novoteris Pharma-Grade Nitric Oxide Product Portfolio
6.4.5 Novoteris Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharma-Grade Nitric Oxide Industry Chain Analysis
7.2 Pharma-Grade Nitric Oxide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharma-Grade Nitric Oxide Production Mode & Process
7.4 Pharma-Grade Nitric Oxide Sales and Marketing
7.4.1 Pharma-Grade Nitric Oxide Sales Channels
7.4.2 Pharma-Grade Nitric Oxide Distributors
7.5 Pharma-Grade Nitric Oxide Customers
8 Pharma-Grade Nitric Oxide Market Dynamics
8.1 Pharma-Grade Nitric Oxide Industry Trends
8.2 Pharma-Grade Nitric Oxide Market Drivers
8.3 Pharma-Grade Nitric Oxide Market Challenges
8.4 Pharma-Grade Nitric Oxide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pharma-Grade Nitric Oxide Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pharma-Grade Nitric Oxide Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pharma-Grade Nitric Oxide Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pharma-Grade Nitric Oxide Sales (K CBM) of Key Manufacturers (2019-2024)
Table 5. Global Pharma-Grade Nitric Oxide Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pharma-Grade Nitric Oxide Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pharma-Grade Nitric Oxide Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pharma-Grade Nitric Oxide Average Price (US$/CBM) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pharma-Grade Nitric Oxide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pharma-Grade Nitric Oxide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pharma-Grade Nitric Oxide, Product Type & Application
Table 12. Global Key Manufacturers of Pharma-Grade Nitric Oxide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pharma-Grade Nitric Oxide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma-Grade Nitric Oxide as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharma-Grade Nitric Oxide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pharma-Grade Nitric Oxide Sales by Region (2019-2024) & (K CBM)
Table 18. Global Pharma-Grade Nitric Oxide Sales Market Share by Region (2019-2024)
Table 19. Global Pharma-Grade Nitric Oxide Sales by Region (2025-2030) & (K CBM)
Table 20. Global Pharma-Grade Nitric Oxide Sales Market Share by Region (2025-2030)
Table 21. Global Pharma-Grade Nitric Oxide Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pharma-Grade Nitric Oxide Revenue Market Share by Region (2019-2024)
Table 23. Global Pharma-Grade Nitric Oxide Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pharma-Grade Nitric Oxide Revenue Market Share by Region (2025-2030)
Table 25. North America Pharma-Grade Nitric Oxide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pharma-Grade Nitric Oxide Sales by Country (2019-2024) & (K CBM)
Table 27. North America Pharma-Grade Nitric Oxide Sales by Country (2025-2030) & (K CBM)
Table 28. North America Pharma-Grade Nitric Oxide Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pharma-Grade Nitric Oxide Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pharma-Grade Nitric Oxide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pharma-Grade Nitric Oxide Sales by Country (2019-2024) & (K CBM)
Table 32. Europe Pharma-Grade Nitric Oxide Sales by Country (2025-2030) & (K CBM)
Table 33. Europe Pharma-Grade Nitric Oxide Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pharma-Grade Nitric Oxide Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pharma-Grade Nitric Oxide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pharma-Grade Nitric Oxide Sales by Region (2019-2024) & (K CBM)
Table 37. Asia Pacific Pharma-Grade Nitric Oxide Sales by Region (2025-2030) & (K CBM)
Table 38. Asia Pacific Pharma-Grade Nitric Oxide Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pharma-Grade Nitric Oxide Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pharma-Grade Nitric Oxide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pharma-Grade Nitric Oxide Sales by Country (2019-2024) & (K CBM)
Table 42. Latin America Pharma-Grade Nitric Oxide Sales by Country (2025-2030) & (K CBM)
Table 43. Latin America Pharma-Grade Nitric Oxide Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pharma-Grade Nitric Oxide Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pharma-Grade Nitric Oxide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pharma-Grade Nitric Oxide Sales by Country (2019-2024) & (K CBM)
Table 47. Middle East & Africa Pharma-Grade Nitric Oxide Sales by Country (2025-2030) & (K CBM)
Table 48. Middle East & Africa Pharma-Grade Nitric Oxide Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pharma-Grade Nitric Oxide Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pharma-Grade Nitric Oxide Sales (K CBM) by Type (2019-2024)
Table 51. Global Pharma-Grade Nitric Oxide Sales (K CBM) by Type (2025-2030)
Table 52. Global Pharma-Grade Nitric Oxide Sales Market Share by Type (2019-2024)
Table 53. Global Pharma-Grade Nitric Oxide Sales Market Share by Type (2025-2030)
Table 54. Global Pharma-Grade Nitric Oxide Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pharma-Grade Nitric Oxide Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pharma-Grade Nitric Oxide Revenue Market Share by Type (2019-2024)
Table 57. Global Pharma-Grade Nitric Oxide Revenue Market Share by Type (2025-2030)
Table 58. Global Pharma-Grade Nitric Oxide Price (US$/CBM) by Type (2019-2024)
Table 59. Global Pharma-Grade Nitric Oxide Price (US$/CBM) by Type (2025-2030)
Table 60. Global Pharma-Grade Nitric Oxide Sales (K CBM) by Application (2019-2024)
Table 61. Global Pharma-Grade Nitric Oxide Sales (K CBM) by Application (2025-2030)
Table 62. Global Pharma-Grade Nitric Oxide Sales Market Share by Application (2019-2024)
Table 63. Global Pharma-Grade Nitric Oxide Sales Market Share by Application (2025-2030)
Table 64. Global Pharma-Grade Nitric Oxide Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pharma-Grade Nitric Oxide Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pharma-Grade Nitric Oxide Revenue Market Share by Application (2019-2024)
Table 67. Global Pharma-Grade Nitric Oxide Revenue Market Share by Application (2025-2030)
Table 68. Global Pharma-Grade Nitric Oxide Price (US$/CBM) by Application (2019-2024)
Table 69. Global Pharma-Grade Nitric Oxide Price (US$/CBM) by Application (2025-2030)
Table 70. Inomax Corporation Information
Table 71. Inomax Description and Business Overview
Table 72. Inomax Pharma-Grade Nitric Oxide Sales (K CBM), Revenue (US$ Million), Price (US$/CBM) and Gross Margin (2019-2024)
Table 73. Inomax Pharma-Grade Nitric Oxide Product
Table 74. Inomax Recent Developments/Updates
Table 75. Praxair Corporation Information
Table 76. Praxair Description and Business Overview
Table 77. Praxair Pharma-Grade Nitric Oxide Sales (K CBM), Revenue (US$ Million), Price (US$/CBM) and Gross Margin (2019-2024)
Table 78. Praxair Pharma-Grade Nitric Oxide Product
Table 79. Praxair Recent Developments/Updates
Table 80. Air Liquide Corporation Information
Table 81. Air Liquide Description and Business Overview
Table 82. Air Liquide Pharma-Grade Nitric Oxide Sales (K CBM), Revenue (US$ Million), Price (US$/CBM) and Gross Margin (2019-2024)
Table 83. Air Liquide Pharma-Grade Nitric Oxide Product
Table 84. Air Liquide Recent Developments/Updates
Table 85. Novoteris Corporation Information
Table 86. Novoteris Description and Business Overview
Table 87. Novoteris Pharma-Grade Nitric Oxide Sales (K CBM), Revenue (US$ Million), Price (US$/CBM) and Gross Margin (2019-2024)
Table 88. Novoteris Pharma-Grade Nitric Oxide Product
Table 89. Novoteris Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Pharma-Grade Nitric Oxide Distributors List
Table 93. Pharma-Grade Nitric Oxide Customers List
Table 94. Pharma-Grade Nitric Oxide Market Trends
Table 95. Pharma-Grade Nitric Oxide Market Drivers
Table 96. Pharma-Grade Nitric Oxide Market Challenges
Table 97. Pharma-Grade Nitric Oxide Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pharma-Grade Nitric Oxide
Figure 2. Global Pharma-Grade Nitric Oxide Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pharma-Grade Nitric Oxide Market Share by Type in 2023 & 2030
Figure 4. 99.92% Purity Product Picture
Figure 5. 99.99% Purity Product Picture
Figure 6. Global Pharma-Grade Nitric Oxide Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pharma-Grade Nitric Oxide Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. Healthcare Centers
Figure 10. Others
Figure 11. Global Pharma-Grade Nitric Oxide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Pharma-Grade Nitric Oxide Market Size (2019-2030) & (US$ Million)
Figure 13. Global Pharma-Grade Nitric Oxide Sales (2019-2030) & (K CBM)
Figure 14. Global Pharma-Grade Nitric Oxide Average Price (US$/CBM) & (2019-2030)
Figure 15. Pharma-Grade Nitric Oxide Report Years Considered
Figure 16. Pharma-Grade Nitric Oxide Sales Share by Manufacturers in 2023
Figure 17. Global Pharma-Grade Nitric Oxide Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Pharma-Grade Nitric Oxide Players: Market Share by Revenue in 2023
Figure 19. Pharma-Grade Nitric Oxide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Pharma-Grade Nitric Oxide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Pharma-Grade Nitric Oxide Sales Market Share by Country (2019-2030)
Figure 22. North America Pharma-Grade Nitric Oxide Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Pharma-Grade Nitric Oxide Sales Market Share by Country (2019-2030)
Figure 26. Europe Pharma-Grade Nitric Oxide Revenue Market Share by Country (2019-2030)
Figure 27. Germany Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Pharma-Grade Nitric Oxide Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Pharma-Grade Nitric Oxide Revenue Market Share by Region (2019-2030)
Figure 34. China Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Pharma-Grade Nitric Oxide Sales Market Share by Country (2019-2030)
Figure 45. Latin America Pharma-Grade Nitric Oxide Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Pharma-Grade Nitric Oxide Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Pharma-Grade Nitric Oxide Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Pharma-Grade Nitric Oxide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Pharma-Grade Nitric Oxide by Type (2019-2030)
Figure 55. Global Revenue Market Share of Pharma-Grade Nitric Oxide by Type (2019-2030)
Figure 56. Global Pharma-Grade Nitric Oxide Price (US$/CBM) by Type (2019-2030)
Figure 57. Global Sales Market Share of Pharma-Grade Nitric Oxide by Application (2019-2030)
Figure 58. Global Revenue Market Share of Pharma-Grade Nitric Oxide by Application (2019-2030)
Figure 59. Global Pharma-Grade Nitric Oxide Price (US$/CBM) by Application (2019-2030)
Figure 60. Pharma-Grade Nitric Oxide Value Chain
Figure 61. Pharma-Grade Nitric Oxide Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
